Cargando…
New Quality-Range-Setting Method Based on Between- and Within-Batch Variability for Biosimilarity Assessment
Analytical biosimilarity assessment relies on two implicit conditions. First, the analytical method must meet a set of requirements known as fit for intended use related to trueness and precision. Second, the manufacture of the reference drug product must be under statistical quality control; i.e.,...
Autores principales: | Oliva, Alexis, Llabrés, Matías |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226621/ https://www.ncbi.nlm.nih.gov/pubmed/34205892 http://dx.doi.org/10.3390/ph14060527 |
Ejemplares similares
-
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars
por: Ebbers, Hans C., et al.
Publicado: (2020) -
Drug Shelf Life and Release Limits Estimation Based on Manufacturing Process Capability
por: Oliva, Alexis, et al.
Publicado: (2023) -
Characterization of Nanoparticle Batch-To-Batch Variability
por: Mülhopt, Sonja, et al.
Publicado: (2018) -
Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur(®)) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency
por: Sinegubova, Maria, et al.
Publicado: (2022) -
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability
por: Burmeister Getz, Elise, et al.
Publicado: (2021)